Kiniksa Pharmaceuticals, Ltd. (KNSA)

NASDAQ: KNSA · IEX Real-Time Price · USD

17.68

+0.59 (3.42%)

At close: Apr 23, 2024, 4:00 PM

17.99

+0.31 (1.75%)

After-hours: Apr 23, 2024, 7:46 PM EDT

Kiniksa Pharmaceuticals Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016
Net Income	14.08	183.36	-157.92	-161.38	-161.87	-103.23	-64.87	-23.97
Depreciation & Amortization	5.4	5.44	4.99	3.81	3.28	0.29	0.03	0.02
Share-Based Compensation	27.15	25.12	25.17	20.88	15.08	5.7	0.9	0.37
Other Operating Activities	-33.33	-208.12	1.47	0.17	-14.86	16.23	13.73	1.72
Operating Cash Flow	13.3	5.81	-126.3	-136.53	-158.37	-81.01	-50.22	-21.87
Operating Cash Flow Growth	129.05%	-	-	-	-	-	-	-
Capital Expenditures	-0.13	-0.01	-0.42	-0.28	-3.2	-5.29	-0.07	-0
Change in Investments	-29.43	-8.06	149.05	-23.16	52.42	-233.91	0	0
Other Investing Activities	-	-	-20	-	-	-	-	-
Investing Cash Flow	-29.56	-8.08	128.64	-23.44	49.21	-239.2	-0.07	-0
Share Issuance / Repurchase	1.5	2.52	5.89	228.22	84.23	159.57	0	0.01
Other Financing Activities	-	-	-	-1.14	-0.12	187.17	39.87	42.5
Financing Cash Flow	1.5	2.52	5.89	227.09	84.11	346.74	39.87	42.51
Net Cash Flow	-14.76	0.25	8.22	67.11	-25.05	26.53	-10.42	20.64
Free Cash Flow	13.17	5.79	-126.71	-136.82	-161.57	-86.3	-50.29	-21.87
Free Cash Flow Growth	127.36%	-	-	-	-	-	-	-
Free Cash Flow Margin	4.87%	2.63%	-328.75%	-	-	-	-	-
Free Cash Flow Per Share	0.19	0.08	-1.85	-2.21	-2.99	-2.92	-27.79	-83.57

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).